
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mindin CRISPR/Cas9 KO Plasmid (h) | sc-417294 | 20 µg | $397.00 |
SPON2 encodes mindin, a secreted extracellular matrix glycoprotein that functions as a pattern-recognition and adhesion molecule linking innate immune sensing to cell–matrix interactions. Mindin binds microbial components and integrin receptors, supporting leukocyte recruitment, macrophage activation, and modulation of inflammatory signaling pathways such as NF-κB and downstream cytokine networks. In stromal and vascular microenvironments, SPON2 contributes to extracellular matrix organization, chemotactic gradients, and tissue remodeling processes that influence tumor–immune interactions. Dysregulated SPON2 expression has been reported across multiple inflammatory and oncogenic contexts, making it relevant for mechanistic studies of immune surveillance, fibrosis-associated remodeling, and microenvironmental signaling.
Mindin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SPON2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SPON2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SPON2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Mindin protein expression.
This CRISPR knockout system enables efficient generation of SPON2-deficient cell models for investigation of Mindin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.